Added value of inflammatory markers to vital signs to predict mortality in patients suspected of severe infection.
Aged
Aged, 80 and over
Blood Pressure
C-Reactive Protein
/ immunology
Clinical Decision-Making
Decision Support Techniques
Erythrocyte Indices
Female
Hospital Mortality
Humans
Inflammation
Intraabdominal Infections
/ blood
Leukocyte Count
Lymphocyte Count
Male
Mean Platelet Volume
Middle Aged
Neutrophils
Organ Dysfunction Scores
Prognosis
Respiratory Rate
Respiratory Tract Infections
/ blood
Retrospective Studies
Sepsis
/ blood
Skin Diseases, Infectious
/ blood
Urinary Tract Infections
/ blood
Biomarkers
Clinical decision-making
Decision support techniques
Infection
Prognosis
Sepsis
Journal
The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
05
08
2019
revised:
14
11
2019
accepted:
17
11
2019
pubmed:
21
12
2019
medline:
25
8
2020
entrez:
21
12
2019
Statut:
ppublish
Résumé
To evaluate the added value of inflammatory markers to vital signs to predict mortality in patients suspected of severe infection. This study was conducted at an acute care hospital (471-bed capacity). Consecutive adult patients suspected of severe infection who presented to either ambulatory care or the emergency department from April 2015 to March 2017 were retrospectively evaluated. A prognostic model for predicting 30-day in-hospital mortality based on previously established vital signs (systolic blood pressure, respiratory rate, and mental status) was compared with an extended model that also included four inflammatory markers (C-reactive protein, neutrophil-lymphocyte ratio, mean platelet volume, and red cell distribution width). Measures of interest were model fit, discrimination, and the net percentage of correctly reclassified individuals at the pre-specified threshold of 10% risk. Of the 1015 patients included, 66 (6.5%) died. The extended model including inflammatory markers performed significantly better than the vital sign model (likelihood ratio test: p < 0.001), and the c-index increased from 0.69 (range 0.67-0.70) to 0.76 (range 0.75-0.77) (p = 0.01). All included markers except C-reactive protein showed significant contribution to the model improvement. Among those who died, 9.1% (95% CI -2.8-21.8) were correctly reclassified by the extended model at the 10% threshold. The inflammatory markers except C-reactive protein showed added predictive value to vital signs. Future studies should focus on developing and validating prediction models for use in individualized predictions including both vital signs and the significant markers.
Identifiants
pubmed: 31859198
pii: S0735-6757(19)30769-7
doi: 10.1016/j.ajem.2019.11.030
pii:
doi:
Substances chimiques
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1389-1395Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest None.